RELIf-CHF: Longterm treatment with ivabradine in ambulatory patients with chronic systolic heart failure - a prospective non-interventional study

Trial Profile

RELIf-CHF: Longterm treatment with ivabradine in ambulatory patients with chronic systolic heart failure - a prospective non-interventional study

Completed
Phase of Trial: Phase IV

Latest Information Update: 18 Jun 2015

At a glance

  • Drugs Ivabradine (Primary)
  • Indications Chronic heart failure
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms RELIf-CHF
  • Sponsors Servier
  • Most Recent Events

    • 29 Apr 2015 Status changed from recruiting to completed as per ISRCTN: Current Controlled Trials record..
    • 02 May 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top